A Phase IV, Randomized, Open-Label, Comparative, Multi-Center Study to Assess the Safety and Efficacy of Advagraf (Modified Release Tacrolimus, Once Daily) After Using Prograf (Tacrolimus Twice Daily) in de Novo Liver Transplant Recipients
Phase of Trial: Phase IV
Latest Information Update: 30 Nov 2018
Price : $35 *
At a glance
- Drugs Tacrolimus (Primary)
- Indications Liver transplant rejection
- Focus Therapeutic Use
- Acronyms Maple
- Sponsors Astellas Pharma
- 08 Mar 2017 Status changed from active, no longer recruiting to completed.
- 29 Nov 2016 Planned End Date changed from 1 Sep 2016 to 1 Jan 2017.
- 29 Nov 2016 Planned primary completion date changed from 1 Sep 2016 to 1 Jan 2017.